KP Tissue Inc. (TSE:KPT – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$11.31 and traded as high as C$13.20. KP Tissue shares last traded at C$13.20, with a volume of 16,152 shares.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the stock. TD increased their price objective on shares of KP Tissue from C$11.00 to C$12.00 and gave the stock a “hold” rating in a research note on Friday, May 15th. Desjardins boosted their target price on shares of KP Tissue from C$12.00 to C$12.50 and gave the company a “hold” rating in a research report on Friday, May 15th. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of C$11.62.
Check Out Our Latest Stock Report on KPT
KP Tissue Stock Performance
KP Tissue (TSE:KPT – Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported C$0.22 earnings per share for the quarter. As a group, equities analysts anticipate that KP Tissue Inc. will post 0.4398964 EPS for the current year.
KP Tissue Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 15th will be issued a $0.21 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 6.4%. KP Tissue’s dividend payout ratio is 80.00%.
Insider Buying and Selling at KP Tissue
In other news, Director David A. Spraley sold 3,668 shares of the firm’s stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of C$13.30, for a total value of C$48,784.40. Following the sale, the director directly owned 15,712 shares in the company, valued at approximately C$208,969.60. This trade represents a 18.93% decrease in their position. In the last 90 days, insiders have sold 6,668 shares of company stock valued at $87,644. Company insiders own 0.14% of the company’s stock.
About KP Tissue
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Further Reading
- Five stocks we like better than KP Tissue
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
